Market Research Logo

Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Acute Myeloid Leukemia patients study in a new report ‘Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia diagnosed patients, and Acute Myeloid Leukemia treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Acute Myeloid Leukemia derived from epidemiological analysis, percentage of patients diagnosed with Acute Myeloid Leukemia, and percentage of patients treated with a therapy.

The study helps executives estimate Acute Myeloid Leukemia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Acute Myeloid Leukemia prevalence, Acute Myeloid Leukemia diagnosis rate, and Acute Myeloid Leukemia treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Acute Myeloid Leukemia Patient Flow
  • Acute Myeloid Leukemia Prevalence
  • Acute Myeloid Leukemia Diagnosed Patients
  • Acute Myeloid Leukemia Treated Patients


1. Acute Myeloid Leukemia: Disease Definition
2. Acute Myeloid Leukemia Patient Flow in Europe
2A. Acute Myeloid Leukemia Prevalence in Europe
2B. Acute Myeloid Leukemia Diagnosed Patients in Europe
2C. Acute Myeloid Leukemia Treated Patients in Europe
3. Acute Myeloid Leukemia Patient Flow in Germany
3A. Acute Myeloid Leukemia Prevalence in Germany
3B. Acute Myeloid Leukemia Diagnosed Patients in Germany
3C. Acute Myeloid Leukemia Treated Patients in Germany
4. Acute Myeloid Leukemia Patient Flow in France
4A. Acute Myeloid Leukemia Prevalence in France
4B. Acute Myeloid Leukemia Diagnosed Patients in France
4C. Acute Myeloid Leukemia Treated Patients in France
5. Acute Myeloid Leukemia Patient Flow in Spain
5A. Acute Myeloid Leukemia Prevalence in Spain
5B. Acute Myeloid Leukemia Diagnosed Patients in Spain
5C. Acute Myeloid Leukemia Treated Patients in Spain
6. Acute Myeloid Leukemia Patient Flow in Italy
6A. Acute Myeloid Leukemia Prevalence in Italy
6B. Acute Myeloid Leukemia Diagnosed Patients in Italy
6C. Acute Myeloid Leukemia Treated Patients in Italy
7. Acute Myeloid Leukemia Patient Flow in UK
7A. Acute Myeloid Leukemia Prevalence in UK
7B. Acute Myeloid Leukemia Diagnosed Patients in UK
7C. Acute Myeloid Leukemia Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Acute Myeloid Leukemia Patient Flow in Europe, 2016
Table 2: Acute Myeloid Leukemia Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Acute Myeloid Leukemia Patient Flow in Germany, 2016
Table 4: Acute Myeloid Leukemia Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Acute Myeloid Leukemia Patient Flow in France, 2016
Table 6: Acute Myeloid Leukemia Patient Flow Forecast in France, 2016 - 2025
Table 7: Acute Myeloid Leukemia Patient Flow in Spain, 2016
Table 8: Acute Myeloid Leukemia Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Acute Myeloid Leukemia Patient Flow in Italy, 2016
Table 10: Acute Myeloid Leukemia Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Acute Myeloid Leukemia Patient Flow in UK, 2016
Table 12: Acute Myeloid Leukemia Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Acute Myeloid Leukemia Patient Flow in Europe, 2016
Figure 2: Acute Myeloid Leukemia Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Acute Myeloid Leukemia Patient Flow in Germany, 2016
Figure 4: Acute Myeloid Leukemia Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Acute Myeloid Leukemia Patient Flow in France, 2016
Figure 6: Acute Myeloid Leukemia Patient Flow Forecast in France, 2016 - 2025
Figure 7: Acute Myeloid Leukemia Patient Flow in Spain, 2016
Figure 8: Acute Myeloid Leukemia Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Acute Myeloid Leukemia Patient Flow in Italy, 2016
Figure 10: Acute Myeloid Leukemia Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Acute Myeloid Leukemia Patient Flow in UK, 2016
Figure 12: Acute Myeloid Leukemia Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report